Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms, Experimental | 4 | 2010 | 33 | 0.950 |
Why?
|
| Immunity, Innate | 4 | 2010 | 82 | 0.880 |
Why?
|
| Neoplasm Regression, Spontaneous | 3 | 2010 | 9 | 0.730 |
Why?
|
| Leukocytes | 3 | 2010 | 60 | 0.680 |
Why?
|
| Neoplasms | 4 | 2010 | 754 | 0.660 |
Why?
|
| Mice | 15 | 2017 | 2571 | 0.600 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2009 | 34 | 0.530 |
Why?
|
| Immunity, Cellular | 2 | 2010 | 21 | 0.520 |
Why?
|
| Granulocytes | 1 | 2017 | 11 | 0.520 |
Why?
|
| BCG Vaccine | 1 | 2017 | 8 | 0.520 |
Why?
|
| Animals | 19 | 2017 | 8199 | 0.490 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 189 | 0.430 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2010 | 20 | 0.380 |
Why?
|
| Mice, Inbred BALB C | 6 | 2010 | 196 | 0.370 |
Why?
|
| Mice, Inbred Strains | 3 | 2006 | 55 | 0.350 |
Why?
|
| Phospholipids | 2 | 2009 | 33 | 0.350 |
Why?
|
| Membrane Glycoproteins | 2 | 2010 | 111 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 6 | 2010 | 792 | 0.320 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2010 | 7 | 0.320 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 22 | 0.320 |
Why?
|
| Glycerophospholipids | 2 | 2007 | 3 | 0.310 |
Why?
|
| Leukocyte Transfusion | 1 | 2009 | 3 | 0.310 |
Why?
|
| Histocompatibility Antigens | 1 | 2009 | 11 | 0.310 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 40 | 0.300 |
Why?
|
| Phosphatidylethanolamines | 3 | 2006 | 8 | 0.290 |
Why?
|
| Sarcoma 180 | 2 | 2010 | 2 | 0.280 |
Why?
|
| Choline-Phosphate Cytidylyltransferase | 2 | 2005 | 2 | 0.280 |
Why?
|
| Immunologic Surveillance | 2 | 2004 | 2 | 0.270 |
Why?
|
| Aging | 2 | 2004 | 942 | 0.260 |
Why?
|
| Phosphatidylcholines | 2 | 2006 | 29 | 0.250 |
Why?
|
| Antibodies, Neoplasm | 1 | 2006 | 16 | 0.250 |
Why?
|
| Orosomucoid | 1 | 2006 | 1 | 0.250 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 729 | 0.240 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2006 | 17 | 0.240 |
Why?
|
| Peritoneal Lavage | 1 | 2005 | 2 | 0.240 |
Why?
|
| Blood Proteins | 1 | 2005 | 19 | 0.230 |
Why?
|
| Methylation | 2 | 2002 | 7 | 0.230 |
Why?
|
| Polyploidy | 1 | 2005 | 1 | 0.230 |
Why?
|
| Gangliosides | 1 | 2005 | 7 | 0.230 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 12 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 33 | 0.230 |
Why?
|
| Brain Chemistry | 1 | 2005 | 46 | 0.220 |
Why?
|
| DNA Replication | 1 | 2005 | 33 | 0.220 |
Why?
|
| Macrophages | 1 | 2006 | 207 | 0.220 |
Why?
|
| Apoptosis | 2 | 2006 | 375 | 0.220 |
Why?
|
| Nevus | 1 | 2004 | 17 | 0.210 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 38 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 64 | 0.190 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 164 | 0.160 |
Why?
|
| Mice, Knockout | 2 | 2010 | 454 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2010 | 184 | 0.120 |
Why?
|
| Humans | 9 | 2017 | 32282 | 0.120 |
Why?
|
| Neutrophils | 1 | 2017 | 120 | 0.120 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 8 | 0.120 |
Why?
|
| Rats | 3 | 2006 | 1895 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2017 | 139 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 237 | 0.120 |
Why?
|
| Cell Line | 3 | 2008 | 454 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2006 | 138 | 0.110 |
Why?
|
| Mice, Nude | 2 | 2006 | 285 | 0.100 |
Why?
|
| Urinary Bladder | 1 | 2017 | 320 | 0.100 |
Why?
|
| Mass Spectrometry | 2 | 2006 | 98 | 0.100 |
Why?
|
| Phenotype | 2 | 2006 | 622 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 164 | 0.090 |
Why?
|
| Choline | 2 | 2002 | 18 | 0.090 |
Why?
|
| Male | 5 | 2010 | 19441 | 0.090 |
Why?
|
| Tumor Escape | 1 | 2010 | 2 | 0.080 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 28 | 0.080 |
Why?
|
| Transplantation Immunology | 1 | 2009 | 30 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3416 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2010 | 121 | 0.070 |
Why?
|
| Cell Survival | 1 | 2010 | 288 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2008 | 100 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2008 | 109 | 0.070 |
Why?
|
| Coenzyme A Ligases | 1 | 2007 | 3 | 0.070 |
Why?
|
| Sex Factors | 1 | 2009 | 655 | 0.070 |
Why?
|
| Female | 3 | 2010 | 19945 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 545 | 0.060 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2006 | 4 | 0.060 |
Why?
|
| Granzymes | 1 | 2006 | 7 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2006 | 11 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 821 | 0.060 |
Why?
|
| Retina | 1 | 2007 | 86 | 0.060 |
Why?
|
| Cell Communication | 1 | 2006 | 37 | 0.060 |
Why?
|
| Necrosis | 1 | 2006 | 54 | 0.060 |
Why?
|
| Phosphatidylinositols | 1 | 2006 | 6 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 20 | 0.060 |
Why?
|
| Lymphocyte Subsets | 1 | 2006 | 7 | 0.060 |
Why?
|
| Phosphatidylserines | 1 | 2006 | 9 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2006 | 80 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 78 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 53 | 0.060 |
Why?
|
| Blood Specimen Collection | 1 | 2005 | 2 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 163 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 146 | 0.060 |
Why?
|
| Chromosome Banding | 1 | 2005 | 3 | 0.060 |
Why?
|
| Diploidy | 1 | 2005 | 3 | 0.060 |
Why?
|
| Cricetulus | 1 | 2005 | 21 | 0.060 |
Why?
|
| CHO Cells | 1 | 2005 | 29 | 0.060 |
Why?
|
| Cricetinae | 1 | 2005 | 51 | 0.060 |
Why?
|
| Cell Size | 1 | 2005 | 40 | 0.060 |
Why?
|
| Stem Cells | 1 | 2007 | 321 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 264 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 897 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 102 | 0.050 |
Why?
|
| Diacylglycerol Cholinephosphotransferase | 1 | 2002 | 1 | 0.050 |
Why?
|
| Choline Kinase | 1 | 2002 | 2 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2002 | 8 | 0.050 |
Why?
|
| Homeostasis | 1 | 2002 | 130 | 0.050 |
Why?
|
| Tubercidin | 1 | 2002 | 1 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 35 | 0.050 |
Why?
|
| Water | 1 | 2002 | 65 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2004 | 220 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2002 | 80 | 0.040 |
Why?
|
| Oxygen | 1 | 2002 | 138 | 0.040 |
Why?
|
| Age Factors | 1 | 2004 | 1179 | 0.040 |
Why?
|
| DNA | 1 | 2002 | 223 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2002 | 727 | 0.040 |
Why?
|
| Child | 1 | 2004 | 2435 | 0.030 |
Why?
|
| Time Factors | 1 | 2002 | 2205 | 0.030 |
Why?
|
| Adolescent | 1 | 2004 | 3519 | 0.030 |
Why?
|
| Adult | 1 | 2004 | 9259 | 0.020 |
Why?
|
| Aged | 1 | 2004 | 10263 | 0.020 |
Why?
|
| Receptors, Calcitriol | 1 | 2008 | 13 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2008 | 19 | 0.020 |
Why?
|
| Dogs | 1 | 2008 | 126 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2007 | 839 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 461 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 603 | 0.010 |
Why?
|